InterventionsHuman trial

Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial

Journal of Diabetes and Its Complications

The paper

Gullaksen S, Vernstrøm L, Sørensen SS et al.

Journal of Diabetes and Its Complications · 29 Aug 2026

doi.org/10.1016/j.jdiacomp.2026.109397 PubMed 42679726

GLP-1 agonists linked to lower dementia risk after COVID-19
Drug Design, Development and Therapy · 5 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Genetically proxied GIP pathway links to lower fracture risk
Diabetes, Obesity & Metabolism · 4 Oct 2026